IPSC 241220 5.00P (IPSC241220P5000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

IPSC241220P5000

Watchlist

0.00
0.000.00%

15min DelayTrading Dec 19 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Clear Street Launches Healthcare & Biotechnology Equity Research
BusinesswireDec 17 14:00 ET
Shinobi Strengthens Leadership to Propel Scalable Immune-Evasive Cell Therapies to the Clinic
PR NewswireDec 17 07:30 ET
Century Therapeutics Faces Termination of BMS Agreement
TipRanksDec 13 17:27 ET
Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...
BenzingaDec 13 17:07 ET
Express News | Century Therapeutics - to Evaluate Opportunities in Aml and Multiple Myeloma
ReutersDec 13 17:03 ET
Express News | Century Therapeutics - Termination Effective March 12, 2025
ReutersDec 13 17:03 ET

Comments

Lose2Win

Dec 18 07:48

$Century Therapeutics (IPSC.US)$ 40 minutes to go buy once market opens or you you will be to late

Lose2Win

Dec 17 23:01

$Century Therapeutics (IPSC.US)$ you cant lose on this theres more to gain than lose 🐮 what are yall waiting for? #Buynow

Jaguar8

Dec 17 13:00

NEWS

$Century Therapeutics (IPSC.US)$
Clear Street Launches Healthcare & Biotechnology Equity Research
Tuesday, 17th December at 2:00 pm
Comprehensive Biotechnology sector market analysis and investment insights complement recently launched Disruptive Technology and Energy Transition franchises
Clear Street, ("Clear Street", "the Company") a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, today announced the expansion of its recently launched equity resear...

Meltyy

May 9 21:51

🚨 April-May 2024 M&A Highlights! 🚨

Keep an eye on these M&As: 👀
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt (ADTX.US)$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics (KTRA.US)$
$Johnson & Johnson (JNJ.US)$ to acquire $ShockWave Medical (SWAV.US)$
$Vertex Pharmaceuticals (VRTX.US)$ to acquire $Alpine Immune (ALPN.US)$
$Century Therapeutics (IPSC.US)$ to acquire Clade Tx
$Eliem Therapeutics (ELYM.US)$ to acquire Tenet Med.
$Incyte (INCY.US)$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals (DCPH.US)$
...

Trytosaveabit

Apr 18 15:58

New 13G

$Century Therapeutics (IPSC.US)$ Century Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Casdin Capital, LLC(6.08%),Eli Casdin(6.08%)